NTBL
Notable Labs Inc.
NASDAQ: NTBL · HEALTHCARE · BIOTECHNOLOGY
$0.25
+0.00% today
Updated 2026-05-01
Market cap
$2.39M
P/E ratio
—
P/S ratio
7.65x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$0 – $0
Volume
2.1M
Notable Labs Inc. (NTBL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-269,000.00%
ROE
-464.30%
ROA
-106.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $562000.00 | $-19.40M | -156.41% | -3,573.31% | -3,451.25% |
| 2020 | $922000.00 | $-24.23M | -72.23% | -2,655.42% | -2,627.44% |
| 2021 | $285000.00 | $-16.05M | -468.77% | -5,934.74% | -5,632.28% |
| 2022 | $8000.00 | $-14.41M | -14,425.00% | -161,550.00% | -180,087.50% |
| 2023 | $310000.00 | $-11.26M | 36.45% | -4,728.06% | -3,633.55% |